Moderna stock was on track to see a weekly gain of 10% as of Wednesday following the first reported bird flu death in the US.

Pfizer (PFE) closed the most recent trading day at $26.91, moving -0.83% from the previous trading session. This change lagged the S&P 500's 0.16% gain on the day. Meanwhile, the Dow experienced a ...

The 12-month price targets assessed by analysts reveal further insights, featuring an average target of $31.0, a high ...

Bird flu has severely impacted poultry farms and cattle herds across 16 states, marking the worst outbreak of its kind.

Johnson & Johnson offers safer payouts and stronger growth. Discover why JNJ stock is the better dividend option compared to ...

Moderna stock was on track to see a weekly gain of 10% as of Wednesday following the first reported bird flu death in the US.

In a report released yesterday, Srikripa Devarakonda from Truist Financial maintained a Buy rating on Pfizer (PFE – Research Report), with a ...

Here's what to expect from the stock market, along with some of Wall Street's hottest trends and most influential businesses, ...

For the current quarter, Pfizer is expected to post earnings of $0.48 per share, indicating a change of +380% from the year-ago quarter. The Zacks Consensus Estimate has changed -3.7% over the last 30 ...

Here are four large-cap value stocks that growth and income investors may want to consider now. History suggests they will ...

Oliver Luxxe Assets LLC lifted its position in Pfizer Inc. (NYSE:PFE – Free Report) by 2.2% during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange ...

Nvidia CEO Jensen Huang will deliver the opening keynote at the CES on Monday, with many analysts viewing the event as a ...